HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of mTOR Pathway by Rapamycin Reduces Brain Damage in Rats Subjected to Transient Forebrain Ischemia.

Abstract
The aims of this study are to clarify the role of mTOR in mediating cerebral ischemic brain damage and the effects of rapamycin on ischemic outcomes. Ten minutes of forebrain ischemia was induced in rats, and their brains were sampled after 3 h, 16 h, and 7 days reperfusion for histology, immunohistochemistry and biochemical analysis. Our data demonstrated that cerebral ischemia resulted in both apoptotic and necrotic neuronal death; cerebral ischemia and reperfusion led to significant increases of mRNA and protein levels of p-mTOR and its downstream p-P70S6K and p-S6; elevation of LC3-II, and release of cytochrome c into the cytoplasm in both the cortex and hippocampus. Inhibition of mTOR by rapamycin markedly reduced ischemia-induced damage; suppressed p-Akt, p-mTOR, p-P70S6K and p-S6 protein levels; decreased LC3-II and Beclin-1; and prevented cytochrome c release in the two structures. All together, these data provide evidence that cerebral ischemia activates mTOR and autophagy pathways. Inhibition of mTOR deactivates the mTOR pathway, suppresses autophagy, prevents cytochrome c release and reduces ischemic brain damage.
AuthorsXiao Yang, Changhun Hei, Ping Liu, Yaozu Song, Taylor Thomas, Sylvie Tshimanga, Feng Wang, Jianguo Niu, Tao Sun, P Andy Li
JournalInternational journal of biological sciences (Int J Biol Sci) Vol. 11 Issue 12 Pg. 1424-35 ( 2015) ISSN: 1449-2288 [Electronic] Australia
PMID26681922 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Cytochromes c
  • mTOR protein, rat
  • TOR Serine-Threonine Kinases
  • Sirolimus
Topics
  • Animals
  • Brain Ischemia (metabolism)
  • Cytochromes c (metabolism)
  • In Situ Nick-End Labeling
  • Prosencephalon (blood supply)
  • RNA, Messenger (genetics)
  • Rats
  • Rats, Sprague-Dawley
  • Sirolimus (pharmacology)
  • TOR Serine-Threonine Kinases (antagonists & inhibitors, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: